U.S. Capital Wealth Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1808915
AUSTIN, TX
Position in REGN
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$1,106,420
+$732,835 QoQ
Shares Held
1,432
+195.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026U.S. Capital Wealth Advisors, LLC holds $11,669,198 across 6 Biotechnology names. REGN ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,537 | $8,118,557 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
66,780 | $2,173,021 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,432 | $1,106,420 | |
| 4 | SMMT |
Summit Therapeutics Inc.
|
12,009 | $227,690 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
15,805 | $26,710 | |
| 6 | IKT |
Inhibikase Therapeutics, Inc.
|
10,000 | $16,800 |
All Filings in REGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,106,420 | 1,432 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $373,585 | 484 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $273,825 | 487 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $240,975 | 459 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $262,571 | 414 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $305,589 | 429 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,286,447 | 2,175 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,285,990 | 2,175 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $2,028,928 | 2,108 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,131,237 | 1,288 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $858,347 | 1,043 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $748,718 | 1,042 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $708,279 | 862 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $621,202 | 861 | Shares | Sole | 2023-02-03 | |
| No filing history on record for this holder in this stock. | ||||||